Home > Insider Trading > Filing (0000950103-21-012568)

Filing Details

Accession Number:: 0000950103-21-012568
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-08-18 18:03:59
Reporting Period:: 2021-08-16

Accepted Time:: 2021-08-18 18:03:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1642545	Shockwave Medical Inc.	SWAV	Surgical & Medical Instruments & Apparatus (3841)	270494101

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1768265	Isaac Zacharias	5403 Betsy Ross Drive Santa Clara CA 95054	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-08-16	1,563	$6.71	60,983	No	4	M	Direct
Common Stock	Acquisiton	2021-08-16	2,437	$4.03	63,420	No	4	M	Direct
Common Stock	Disposition	2021-08-16	900	$183.24	62,520	No	4	S	Direct
Common Stock	Disposition	2021-08-16	600	$183.81	61,920	No	4	S	Direct
Common Stock	Disposition	2021-08-16	128	$185.04	61,792	No	4	S	Direct
Common Stock	Disposition	2021-08-16	800	$187.29	60,992	No	4	S	Direct
Common Stock	Disposition	2021-08-16	102	$188.31	60,890	No	4	S	Direct
Common Stock	Disposition	2021-08-16	800	$190.08	60,090	No	4	S	Direct
Common Stock	Disposition	2021-08-16	670	$190.87	59,420	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2021-08-16	1,563	$0.00	1,563	$6.71
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2021-08-16	2,437	$0.00	2,437	$4.03

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
54,759		2028-11-14	No	4	M	Direct
54,176		2028-04-10	No	4	M	Direct

Footnotes

All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/14/2021.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $182.58 to $183.55. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $183.58 to $184.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $184.98 to $185.26. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $186.89 to $187.77. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $188.27 to $188.31. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $189.50 to $190.38. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $190.59 to $191.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Twenty-five percent of the shares subject to the option vested on 11/9/2019 and the balance of the shares are scheduled to vest in equal monthly installments thereafter for 36 months.
Twenty-five percent of the shares subject to the option vested on 3/1/2019 and the balance of the shares are scheduled to vest in equal monthly installments thereafter for 36 months.
Due to a clerical error, the Form 4 which was filed by the reporting person on December 16, 2020 incorrectly stated that the holdings for this option was 42,345. The actual number of holdings was 68,345. The current holdings have been updated to reflect this correction.